title: Superoxide anion scavengers restore NO-mediated pulmonary vasodilation after lung transplantation.
abstract: Left lung autotransplantation (LLA) results in a chronic attenuation in endothelium-dependent, nitric oxide (NO)-mediated pulmonary vasodilation. We tested the hypothesis that this abnormality involves a decrease in the effective concentration of NO due to inactivation by superoxide anion. Size- and position-matched pulmonary arterial rings were isolated from the right (control) and left (LLA) lungs of seven dogs 1-5 mo post-LLA. The rings were suspended for isometric tension recording and contracted with phenylephrine, and cumulative dose-response curves for ACh or calcium ionophore (A-23187) were generated. Endothelium-dependent relaxation to ACh was inhibited post-LLA, with the maximum vasorelaxation response reduced from 88 +/- 5 to 63 +/- 5% (P < 0. 01) post-LLA. In contrast, after pretreatment with the superoxide anion scavengers tiron or superoxide dismutase (SOD), the dose-response relationships for ACh were similar in control and LLA rings. Oxypurinol, which inhibits superoxide anion production by endothelial xanthine oxidase, also restored the vasorelaxation response to ACh in LLA rings. The pulmonary vasorelaxant response to A-23187 was also attenuated (P < 0.01) post-LLA, and this effect was entirely reversed by pretreatment with tiron, SOD, or oxypurinol. These results indicate that the attenuated responses to these pulmonary vasorelaxants post-LLA involve inactivation of NO by superoxide anion generated by endothelial xanthine oxidase.
authors.affiliation: Center for Anesthesiology Research, Division of Anesthesiology and Critical Care Medicine, Ohio 43210, USA.
authors.forename: S
authors.initials: S
authors.lastname: Seki
authors.forename: N A
authors.initials: NA
authors.lastname: Flavahan
authors.forename: N G
authors.initials: NG
authors.lastname: Smedira
authors.forename: P A
authors.initials: PA
authors.lastname: Murray
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D004285:Dogs; D004791:Enzyme Inhibitors / Q000494:pharmacology; D016166:Free Radical Scavengers / Q000494:pharmacology*; D066298:In Vitro Techniques; D007476:Ionophores / Q000494:pharmacology; D016040:Lung Transplantation; D008297:Male; D009569:Nitric Oxide / Q000502:physiology*; D010117:Oxypurinol / Q000494:pharmacology; D011184:Postoperative Period; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology*; D013482:Superoxide Dismutase / Q000494:pharmacology; D013481:Superoxides / Q000378:metabolism*; D014664:Vasodilation / Q000502:physiology*; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D016166:Free Radical Scavengers; D007476:Ionophores; D014665:Vasodilator Agents; D013481:Superoxides; D009569:Nitric Oxide; D000001:Calcimycin; D013482:Superoxide Dismutase; D010117:Oxypurinol; D000109:Acetylcholine